Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center
Year: 2011
Type: article
Study design: Clinical Trial
Source: Critical Care Medicine
Authors: Antoine Froissart, Marc Buffet, Agnès Veyradier, Pascale Poullin, François Provôt, Sandrine Malot, Michael Schwarzinger, Lionel Galicier, Philippe Vanhille, Jean-Paul Vernant, Dominique Bordessoule, Bertrand Guidet, Elie Azoulay, Eric Mariotte, Eric Rondeau, Jean-Paul Mira, Alain Wynckel, Karine Clabault, Gabriel Choukroun, Claire Presne, Jacques Pourrat, Mohamed Hamidou, Paul Coppo
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2028444448
